# Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia

> **NCT00447772** · PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 516 (actual)

## Conditions studied

- Cervical Dystonia

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT00447772
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2008-02
- **Final completion:** 2008-04
- **Target enrollment:** 516 (ACTUAL)
- **Last updated:** 2023-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447772, "Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00447772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*